Physician profile
Peter O Simon
NPI 1982644928
$1,626.65
in general payments reported to CMS, 2019-2025
14 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2021: $58.10 · 2023: $685 · 2024: $145 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $536.63 | 2023-2024 | Auryon Laser System 100-120 Vac, Alphavac |
| Cook Medical LLC | $308.91 | 2019-2023 | Zilver Vena, Tornado |
| Penumbra, INC. | $297.60 | 2019-2025 | Penumbra System |
| Sirtex Medical INC | $98.53 | 2025 | Lava Les (Liquid Embolic System) |
| W. L. Gore & Associates, INC. | $73.46 | 2019 | |
| Siemens Medical Solutions USA, INC. | $70.49 | 2019-2024 | Cios Select |
| Bard Peripheral Vascular, INC. | $51.22 | 2021-2024 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $45.81 | 2024 | Rubicon 18, Ekosonic |
| Inari Medical, INC. | $41.23 | 2021 | |
| Route 92 Medical, INC. | $28.46 | 2025 | |
| Philips North America LLC | $25.04 | 2025 | Zenition 90 M |
| Abbott Laboratories | $24.24 | 2024 | Diamondback Peripheral |
| Depuy Synthes Sales INC. | $23.05 | 2019 | |
| Cardiovascular Systems INC. | $1.98 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.